ARTICLE | Clinical News
Mechlorethamine regulatory update
August 1, 2011 7:00 AM UTC
Yaupon submitted an NDA to FDA for a gel formulation of mechlorethamine to treat early stage mycosis fungoides, a type of cutaneous T cell lymphoma (CTCL). The topical form of nitrogen mustard, an alk...